SCHEMBL7793271

SCHEMBL7793271

Cc1ccc([N][C@@H]2CCCC[C@H]2O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 3/20 0.46
HTR3E A5X5Y0 2/20 0.36
HTR3B O95264 2/20 0.36
HTR3A P46098 2/20 0.36
HTR3D Q70Z44 2/20 0.36
HTR3C Q8WXA8 2/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
SLC22A3 O75751 1/20 0.36
PLAU P00749 1/20 0.36
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
CYP2C19 P33261 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
CYP1A2 P05177 3/20 0.35
HPGD P15428 1/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C9 P11712 2/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2478208 0.75 CYP1A2 (0.38) SLC18A3HTR3EHTR3BHTR3AHTR3D
SCHEMBL7794041 0.74 NPC1 (0.38) SLC18A3HTR3EHTR3BHTR3AHTR3D
SCHEMBL7794523 0.71 HTR3E (0.37) SLC18A3HTR3EHTR3BHTR3AHTR3D
SCHEMBL7793328 0.71 HTR3E (0.38) SLC18A3HTR3EHTR3BHTR3AHTR3D
SCHEMBL7784569 0.70 ACHE (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1138540 0.68 SLC18A3 (0.53) SLC18A3CYP2C19CYP1A2CYP3A4CYP2C9
SCHEMBL18415611 0.68 SMN1; SMN2 (0.49) SLC18A3NPC1RAB9ACYP2C19SMN1; SMN2
SCHEMBL20194474 0.68 SMN1; SMN2 (0.49) SLC18A3NPC1RAB9ACYP2C19SMN1; SMN2
SCHEMBL7793274 0.68 SMN1; SMN2 (0.49) SLC18A3NPC1RAB9ACYP2C19SMN1; SMN2
SCHEMBL8741836 0.66 RAB9A (0.54) NPC1RAB9ACYP2C19SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed